A report from the 72nd Scientific Sessions of the American Diabetes Association (June 8-12, 2012 - Philadelphia, Pennsylvania, USA).
The 72nd Scientific Sessions of the American Diabetes Association were held this year in Philadelphia. Here, new findings with currently available drugs and drugs in advanced clinical research were reported during the meeting's oral and poster sessions and are summarized in the following report.
Thomson Reuters, Barcelona, Spain. xavier.rabasseda@thomsonreuters.com
X
X
Rabasseda
D002318:Cardiovascular Diseases / Q000209:etiology / Q000517:prevention & control; D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy* / Q000503:physiopathology / Q000628:therapy; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy* / Q000503:physiopathology / Q000628:therapy; D050171:Dyslipidemias / Q000150:complications / Q000628:therapy; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D007167:Immunotherapy / Q000379:methods; D009765:Obesity / Q000150:complications / Q000628:therapy
D007004:Hypoglycemic Agents